We are live on ! Find out more
AAP

Ardsley Advisory Partners Portfolio holdings

AUM $960M
1-Year Est. Return 207.76%
This Fund
S&P 500
This Quarter Est. Return
+10.08%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$644M
AUM Growth
+$39.6M
Cap. Flow
+$5.56M
Cap. Flow %
0.86%
Top 10 Hldgs %
35.41%
Holding
200
New
77
Increased
40
Reduced
23
Closed
50

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$14.2M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.7M
3
CELG
Celgene Corp
CELG
+$12.4M
4
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$8.27M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$7.96M

Top Sells

Rank Stock Value
1
NRF
NorthStar Realty Finance Corp.
NRF
+$15M
2
AKRX
Akorn Inc
AKRX
+$12.7M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$9.32M
4
GLBL
TerraForm Global, Inc. Class A Common Stock
GLBL
+$7.95M
5
MRT
MedEquities Realty Trust, Inc.
MRT
+$7.26M

Sector Composition

Rank Sector Weight
1 Healthcare 13.08%
2 Technology 10.1%
3 Financials 8.58%
4 Energy 7.12%
5 Real Estate 6.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BNFT
126
DELISTED
Benefitfocus, Inc.
BNFT
$252K 0.04%
+9,000
New +$258K
ALXN
127
DELISTED
Alexion Pharmaceuticals
ALXN
$242K 0.04%
+2,000
New +$258K
EW icon
128
Edwards Lifesciences
EW
$50B
$235K 0.04%
+7,500
New +$235K
NKTR icon
129
Nektar Therapeutics
NKTR
$2.41B
$235K 0.04%
+667
New +$150K
TBT icon
130
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$300M
$235K 0.04%
6,000
– –
ABEO icon
131
Abeona Therapeutics
ABEO
$369M
$224K 0.03%
1,800
+200
+13% +$25.8K
ZGNX
132
DELISTED
Zogenix, Inc.
ZGNX
$217K 0.03%
+20,000
New +$203K
MRVL icon
133
Marvell Technology
MRVL
$165B
$214K 0.03%
14,000
-23,500
-63% -$362K
BOLD
134
DELISTED
Audentes Therapeutics, Inc
BOLD
$214K 0.03%
+12,572
New +$203K
PI icon
135
Impinj
PI
$4.49B
$212K 0.03%
+7,000
New +$220K
ALDR
136
DELISTED
Alder Biopharmaceuticals
ALDR
$208K 0.03%
+10,000
New +$221K
MDT icon
137
Medtronic
MDT
$110B
$201K 0.03%
+2,500
New +$195K
TLGT
138
DELISTED
Teligent, Inc
TLGT
$195K 0.03%
2,500
-1,000
-29% -$72K
NVTR
139
DELISTED
Nuvectra Corporation Common Stock
NVTR
$185K 0.03%
+27,095
New +$185K
UA icon
140
Under Armour Class C
UA
$2.85B
$183K 0.03%
+10,000
New +$208K
BLDR icon
141
Builders FirstSource
BLDR
$7.1B
$171K 0.03%
+11,500
New +$149K
TWTR
142
DELISTED
Twitter, Inc.
TWTR
$150K 0.02%
+10,000
New +$162K
ENTL
143
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$138K 0.02%
+10,000
New +$161K
ENPH icon
144
Enphase Energy
ENPH
$4.94B
$137K 0.02%
+100,000
New +$146K
CBAY
145
DELISTED
Cymabay Therapeutics
CBAY
$130K 0.02%
30,210
+15,000
+99% +$43K
CORV
146
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$120K 0.02%
40,000
+11,100
+38% +$32.7K
CGRN
147
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$115K 0.02%
15,000
+4,147
+38% +$31.1K
IMMU
148
DELISTED
Immunomedics Inc
IMMU
$65K 0.01%
+10,000
New +$50.7K
TTI icon
149
TETRA Technologies
TTI
$1.13B
$63K 0.01%
+15,500
New +$69.7K
HROW icon
150
Harrow
HROW
$1.45B
$42K 0.01%
+10,000
New +$26K
4 5
6
7 8

Similar funds

NA
Navellier & Associates Reno, Nevada $960M AUM 79.37% 1-Year Est. Return
MK
MASTERINVEST Kapitalanlage Vienna $962M AUM 27.59% 1-Year Est. Return
QIM
Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return
JVBC
J.V. Bruni & Co Colorado Springs, Colorado $958M AUM 22.2% 1-Year Est. Return
TFP
Triple Frond Partners San Francisco, California $963M AUM 27.45% 1-Year Est. Return
UWPG
Ullmann Wealth Partners Group Jacksonville Beach, Florida $963M AUM 17.06% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Ardsley Advisory Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Ardsley Advisory Partners held 200 positions worth $644M, up 6.6% from $604M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ardsley Advisory Partners's Q1 2017 filing shows 77 new, 40 increased, 23 reduced and 50 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M. The largest sale was NorthStar Realty Finance Corp., an estimated $15M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

  • Ardsley Advisory Partners's largest Q1 2017 buy was BioMarin Pharmaceuticals: 89,500 shares worth $7.86M.
  • Ardsley Advisory Partners added most to State Street SPDR S&P Biotech ETF in Q1 2017, an estimated $14.2M increase.
  • Ardsley Advisory Partners's biggest Q1 2017 reduction was Akorn Inc, cutting an estimated $12.7M.
  • Ardsley Advisory Partners fully exited NorthStar Realty Finance Corp. in Q1 2017, selling an estimated $15M.
  • Ardsley Advisory Partners's ten largest holdings make up 35% of its $644M portfolio in Q1 2017.
  • Ardsley Advisory Partners opened 77 new positions and closed 50 in Q1 2017.
  • Ardsley Advisory Partners's portfolio value rose 6.6% quarter-over-quarter to $644M.

Based on Ardsley Advisory Partners's 13F filing for Q1 2017, filed 15 May 2017.